Abstract

Australia’s focus on biotechnology began in the 1990s, although this industry has been active in the country since the 1970s. Australia’s traditional strengths in medical and agricultural research have helped the country to move up the global biotech value-chain in a very short time. The Australian economy is relatively small compared to other biotech behemoths such as the United States and Japan and the government has realized the importance of innovation through industries such as biotechnology to boost the economy. This has translated into generous research funding and a favorable policy atmosphere for the industry, which in turn has grown steadily. The following White Paper builds a global, regional, and country perspective on the biotechnology industry and analyzes the competitive position of Australian biotech companies. The White Paper also elucidates key strategies for Australian biotech companies for achieving sustainable growth.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call